title: Release the hounds: virotherapy with immunotherapy.
abstract: In this issue of Blood, Shen et al demonstrate that the vesicular stomatitis virus (VSV)-murine interferon β (IFNβ)-sodium iodide symporter (NIS) (VSV-mIFNβ-NIS) oncolytic virus has significant antileukemia activity, which is enhanced when combined with an anti-programmed death-ligand 1 (PD-L1) antibody.
authors.affiliation: MD ANDERSON CANCER CENTER.
authors.forename: Tapan M
authors.initials: TM
authors.lastname: Kadia
mesh_terms: D000818:Animals; D060890:B7-H1 Antigen / Q000276:immunology*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D050130:Oncolytic Virotherapy; D014721:Vesicular stomatitis Indiana virus / Q000502:physiology*
chemical_list: D060890:B7-H1 Antigen